1. 1154PA phase I study of MEDI1873, a novel GITR agonist, in advanced solid tumors. (23rd October 2018) Authors: Denlinger, C S; Infante, J R; Aljumaily, R; Naing, A; Chintakuntlawar, A; Rizvi, N A; Ross, H; Gordon, M; Kumar, R; Ma, M; Yan, L; Vicini, P; Standifer, N; Cann, J; Perera, A; Durham, N; Krishnan, S; Balmanoukian, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and clinical activity of atezolizumab in head and neck cancer: results from a phase I trial. (13th September 2018) Authors: Colevas, A D; Bahleda, R; Braiteh, F; Balmanoukian, A; Brana, I; Chau, N G; Sarkar, I; Molinero, L; Grossman, W; Kabbinavar, F; Fassò, M; O'Hear, C; Powderly, J Journal: Annals of oncology Issue: Volume 29:Number 11(2018) Page Start: 2247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗